Medical-Grade Silicone Elastomers Market Global Report 2026

The medical-grade silicone elastomers market size has grown strongly in recent years. It will grow from $0.84 billion in 2025 to $0.9 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing adoption of silicone-based medical devices, growing demand for flexible medical components, rising use of silicone in long-term implantable devices, increasing demand for sterilization-compatible materials, and growing need for chemically resistant medical polymers.

The medical-grade silicone elastomers market size is expected to see strong growth in the next few years. It will grow to $1.16 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. Growth during the forecast period is anticipated to be driven by rising demand for advanced biocompatible elastomer formulations, increasing adoption of minimally invasive medical technologies, growing development of wearable and implantable medical devices, increasing demand for high-purity and low-leachable materials, and expanding use of advanced liquid silicone processing technologies. Major trends during the forecast period include increasing adoption of high-purity medical-grade silicone elastomers, growing demand for sterilization-resistant silicone formulations, rising use of liquid silicone elastomers in medical applications, increasing demand for platinum-cured silicone elastomers, and growing development of low-extractable and low-leachable silicone materials.

The increasing demand for long-term implantable medical devices is expected to propel the growth of the medical-grade silicone elastomers market going forward. Long-term implantable medical devices are medical products designed to remain inside the human body for extended periods to support, restore, replace, or monitor physiological functions. The demand for long-term implantable medical devices is increasing due to the aging population and the growing recognition of the benefits offered by silicone materials in implantable healthcare applications. Medical-grade silicone elastomers support long-term implantable medical devices by providing excellent biocompatibility, flexibility, durability, and long-term performance in applications such as pacemakers and implanted prosthetics. For instance, in 2024, according to the U.S. Food and Drug Administration (FDA), a US-based federal agency responsible for regulating medical devices, regulatory activity for totally implanted spinal cord stimulation systems increased to approximately 94 PMA actions, compared with approximately 63 actions in 2023. Therefore, the increasing demand for long-term implantable medical devices is driving the growth of the medical-grade silicone elastomers market.

Major companies operating in the medical-grade silicone elastomers market are concentrating on developing liquid silicone rubber to address the growing demand for advanced wearable, diagnostic, and minimally invasive medical devices. Liquid silicone rubber is a two-component, platinum-cured silicone elastomer that provides high purity, biocompatibility, flexibility, thermal stability, and precision molding capabilities, making it suitable for producing complex medical components with tight dimensional tolerances. For instance, in October 2025, Elkem, a Norway-based silicone materials company, launched SILBIONE LSR Select EC 70, a medical-grade electrically conductive liquid silicone rubber developed for wearable and diagnostic healthcare devices. The material combines certified biocompatibility with stable electrical conductivity, supports precision liquid injection molding for complex component manufacturing, and enables reliable signal transmission in skin-contact medical devices.

In May 2025, Trelleborg, a Sweden-based engineered polymer solutions company, acquired Sico Gesellschaft für Siliconverarbeitung mbH and Sico Silicone s.r.o. for an undisclosed amount. The acquisition strengthened Trelleborg's silicone rubber capabilities and broadened its portfolio of silicone-based solutions for healthcare applications. Sico Gesellschaft für Siliconverarbeitung mbH is a Germany-based manufacturer of customized silicone rubber products. Sico Silicone s.r.o. is a Czech Republic-based manufacturer of silicone rubber components.

Major companies operating in the medical-grade silicone elastomers market are Shin-Etsu Chemical Co. Ltd., DuPont de Nemours Inc., Wacker Chemie AG, Elkem ASA, Momentive Performance Materials Inc., Avantor Inc., Compagnie de Saint-Gobain SA, Freudenberg SE, Trelleborg AB, Specialty Silicone Products Inc., Stockwell Elastomerics Inc., SIMTEC Silicone Parts LLC, Silicone Engineering Ltd., Primasil Silicones Ltd., RAUMEDIC AG, INOAC Corporation, Precision Associates Inc., Silcotech North America Inc., Polyzen Inc., Rosti Group, Silikon-Technik Siltec GmbH, Rubbercraft Corporation, MME Group Inc., Silex Silicones Ltd., Reiss Manufacturing Inc., Rogers Corporation, KCC Corporation, CHT Group, Dow Inc., Syensqo SA.

North America was the dominating region in the medical-grade silicone elastomers market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the medical-grade silicone elastomers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical-grade silicone elastomers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.